Showing 5001-5010 of 5771 results for "".
- Clinreg Consulting Services Appoints New President and Plans to Expand Consulting Teamhttps://modernod.com/news/clinreg-consulting-services-appoints-new-president-and-plans-to-expand-consulting-team/2476920/Clinreg Consulting Services, a provider of regulatory, clinical, statistical, data management, and quality consulting services, announced the appointment of Lee Kramm, MD, MSE, as President and plans to expand its con
- Nicox Completes Enrollment of NCX 4251 Phase 2 Trial with Topline Results on Track for Q4 2019https://modernod.com/news/nicox-completes-enrolment-of-ncx-4251-phase-2-trial-with-top-line-results-on-track-for-q4-2019/2476918/Nicox SA announced that it has completed enrollment in its multicenter, dose escalating, US phase 2 clinical trial evaluating the safety and tolerability of NCX 4251 in acute exacerbations of blepharitis. The primary objective of this
- Tangible Science and VSP Optics Co-develop New Daily Disposable Silicone Hydrogel Contact Lenshttps://modernod.com/news/tangible-science-and-vsp-optics-co-develop-new-daily-disposable-silicone-hydrogel-contact-lens/2476916/Tangible Science announced the launch of Unity BioSync contact lenses, which the company is describing as the first daily disposable silicone hydrogel contact lens featuring a modified formula of the patented Tangible Hydra-PEG polymer technology that is bonded to the surface of the lens. Co-deve
- Eversight to Offer Preloaded DMEK in DORC Tubehttps://modernod.com/news/eversight-first-to-offer-preloaded-dmek-in-dorc-tube/2476911/Eversight announced it is the first eye bank to prepare preloaded Descemet membrane endothelial keratoplasty (DMEK) tissue in the Melles DORC tube, offering corneal surgeons more preloaded tissue options that further streamline surgeries and reduce cost, according to a company news release. <
- Novo Nordisk’s Rybelsus Gains FDA Approval as First Oral GLP-1 Receptor Agonist for Type 2 Diabeteshttps://modernod.com/news/novo-nordisks-rybelsus-gains-fda-approval-as-first-oral-glp-1-receptor-agonist-for-type-2-diabetes/2476907/The FDA announced Friday the approval of Novo Nordisk’s Rybelsus (semaglutide) to improve control of blood glucose in adults with type 2 diabetes, along with diet and exercise, making it the first oral GLP-1 receptor agonist cleared in the US. Lisa Yanoff, acting director of the Division of
- CooperVision Seeks Submissions for 2020 Best Practices Honoreeshttps://modernod.com/news/coopervision-seeks-submissions-for-2020-best-practices-honorees/2476909/Among thousands of eye care professionals at Vision Expo West in Las Vegas, CooperVision announced today its fifth annual search for the nation’s 2020 Best Practices (
- Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa in the European Unionhttps://modernod.com/news/aerie-pharmaceuticals-receives-positive-chmp-opinion-for-rhokiinsa-in-the-european-union/2476906/Aerie Pharmaceuticals announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of the marketing authorization application (MAA) for Rhokiinsa (netarsudilophthalmic solution) 0.02%. The recommend
- Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseaseshttps://modernod.com/news/boehringer-ingelheim-partners-with-inflammasome-therapeutics-to-develop-novel-therapies-for-patients-with-retinal-diseases/2476903/Boehringer Ingelheim and Inflammasome Therapeutics announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases. By combining Inflammasome’s unique intravitreal (IVT) drug delivery technologies with Boehringer Ingelhei
- Sifi Appoints New Country Manager for Italyhttps://modernod.com/news/sifi-appoints-new-country-manager-for-italy/2476904/Sifi has announced that Fabrizio Folco has joined the company as “Country Manager Italy,” and will be responsible for accelerating company development on the Italian market through management of the company’s commercial strategy and organization, for both pharma and surgical are
- US House Speaker Nancy Pelosi Introduces Plan to Permit Price Negotiation for Some Drugshttps://modernod.com/news/us-house-speaker-nancy-pelosi-introduces-plan-to-permit-price-negotiation-for-some-drugs/2476901/US House Speaker Nancy Pelosi on Thursday unveiled proposed legislation that would permit the federal government to negotiate prices of drugs for Medicare and other health programs. Specifically, the proposal would empower the Department of Health and Human Services (HHS) to annually ne